NovoCure Ltd — Director's Dealing 2020

Mar 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-02-27

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-27	Ordinary Shares	M	7716	—	Acquired	119484	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-27	Restricted Stock Units	$0.0	M	7716	Disposed		Ordinary Shares (7716.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.